Applying explainable artificial intelligence methods to models for diagnosing personal traits and cognitive abilities by social network data

Panfilova, Anastasia S.; Turdakov, Denis Yu.

doi:10.1038/s41598-024-56080-8

Cited by 3 publications

References 52 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

The roles of patient‐derived xenograft models and artificial intelligence toward precision medicine

Janitri,

ArulJothi,

Ravi Mythili

et al. 2024

MedComm

View full text Add to dashboard Cite

Patient‐derived xenografts (PDX) involve transplanting patient cells or tissues into immunodeficient mice, offering superior disease models compared with cell line xenografts and genetically engineered mice. In contrast to traditional cell‐line xenografts and genetically engineered mice, PDX models harbor the molecular and biologic features from the original patient tumor and are generationally stable. This high fidelity makes PDX models particularly suitable for preclinical and coclinical drug testing, therefore better predicting therapeutic efficacy. Although PDX models are becoming more useful, the several factors influencing their reliability and predictive power are not well understood. Several existing studies have looked into the possibility that PDX models could be important in enhancing our knowledge with regard to tumor genetics, biomarker discovery, and personalized medicine; however, a number of problems still need to be addressed, such as the high cost and time‐consuming processes involved, together with the variability in tumor take rates. This review addresses these gaps by detailing the methodologies to generate PDX models, their application in cancer research, and their advantages over other models. Further, it elaborates on how artificial intelligence and machine learning were incorporated into PDX studies to fast‐track therapeutic evaluation. This review is an overview of the progress that has been done so far in using PDX models for cancer research and shows their potential to be further improved in improving our understanding of oncogenesis.

show abstract